Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Working Life: Jo Ferdinando

June 22, 2010 Manufacturing and Production, Research and Development Shire, Working Life, careers

How did you find your way into your most current role? After completing a BSc in Microbiology and Virology at …
Feature
Andrew Witty

Let’s avoid further stand-offs, says Witty

June 22, 2010 Research and Development, Sales and Marketing EFPIA, Greece, industry, pricing

Pharma will need to find new ways of working with European governments in order to avoid further crises as witnessed …
News

Dr Geoffrey Nichol joins Ikaria

June 22, 2010 Research and Development Ikaria, appointment, research and development

US biotherapeutics company Ikaria has appointed Dr Geoffrey Nichol chief medical officer, with responsibility for its late-stage drug development activies. …
Appointment
Blog footer

Digital Pharma: Online trial safety reporting

June 21, 2010 Research and Development FDA, MHRA, digital research, drug safety

From September all serious adverse events that occur during clinical trials in the UK will have to be reported electronically …
News

Tasigna more effective than Glivec, says Novartis

June 21, 2010 Research and Development, Sales and Marketing Glivec, Novartis, Tasigna, leukaemia

Novartis has gained US approval for Tasigna to be used as a front line treatment for chronic myeloid leukaemia. The …
News
NHS Football Fitness

Digital Pharma: Byte-sized roundup

June 18, 2010 Medical Communications, Research and Development FDA, Genzyme, NHS, Pfizer, digital pharma med coms, digital pharma research, social media

This week’s roundup includes an NHS football fitness game, Pfizer’s virtual exhibition booth, Amgen’s oncology site, reports FDA social media …
News

Contract research news in brief

June 18, 2010 Research and Development CRO, ClinStar, Covance, ICON, Parexel, Phlexglobal, Quintiles, chiltern, contract research

Good news abounds in the CRO sector at the moment, with a raft of business expansions, investments, and new contracts …
News

Bayer signs cancer stem cell research deal

June 18, 2010 Research and Development Bayer Schering Pharma, Cancer, OncoMed, Stem cells

Bayer Schering Pharma has teamed up with a US oncology specialist to develop novel antibodies, protein therapeutics and small molecules …
News

MedImmune Ventures appoints Ron Laufer

June 18, 2010 Research and Development AstraZeneca, MedImmune, appointment, research and development

Ron Laufer has joined MedImmune’s venture capital arm as senior managing director. The company, which is the worldwide biologics unit …
Appointment

Trials of cancer vaccine Stimuvax can resume

June 17, 2010 Research and Development Merck Serono, Stimuvax, cancer vaccine, vaccines

Merck Serono has been given clearance to resume part of its clinical trials of its cancer vaccine Stimuvax. Trials of …
News

UCB’s new lupus treatment promising

June 17, 2010 Research and Development Benlysta, Lupus, UCB, epratuzumab

A new monoclonal antibody treatment for lupus has shown promise in phase II trials, according to UCB. The biopharmaceutical company …
News

ABPI appoints former AZ innovation head

June 17, 2010 Research and Development, Sales and Marketing ABPI, appointment, research and development, sales and marketing

UK industry association the ABPI has appointed Carol Blount as its new head of commercial affairs. Carol has more than …
Appointment
Tom McKillop and Fred Goodwin

Reinventing Management

June 17, 2010 Research and Development, Sales and Marketing management

The investment banking industry officially ceased to exist on September 21, 2008. That was the day the last two remaining …
Feature

FDA to make safety reviews public

June 16, 2010 Research and Development, Sales and Marketing FDA, drug safety

The US medicines regulator is to make safety reviews of recently approved prescription medicines more readily available to the public. …
News

Former FDA and MHRA regulators join Parexel Consulting

June 16, 2010 Research and Development CRO, Parexel, appointment, research and development

Parexel Consulting has appointed former regulators Toby Silverman, M.D. and Keith Watson, Ph.D. as principal consultants. The company is a …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025